Abstract

For cosmetic and reconstructive purposes in the setting of small-volume adipose tissue damage due to aging, traumatic defects, oncological resections, and degenerative diseases, the current strategies for soft tissue replacement involve autologous fat grafts and tissue fillers with synthetic, bioactive, or tissue-engineered materials. However, they all have drawbacks such as volume shrinkage and foreign-body responses. Aiming to regenerate bioactive vascularized adipose tissue on biomaterial scaffolds, adipose tissue engineering (ATE) has emerged as a suitable substitute for soft tissue repair. The essential components of ATE include scaffolds as support, cells as raw materials for fat formation, and a tolerant local environment to allow regeneration to occur. The commonly loaded seeding cells are adipose-derived stem cells (ASCs), which are expected to induce stable and predictable adipose tissue formation. However, defects in stem cell enrichment, such as donor-site sacrifice, limit their wide application. As a promising alternative approach, cell-free bioactive scaffolds recruit endogenous cells for adipogenesis. In biomaterials without cell seeds, the key to sufficient adipogenesis relies on the recruitment of endogenous host cells and continuous induction of cell homing to scaffolds. Regeneration, rather than repair, is the fundamental dominance of an optimal mature product. To induce in situ adipogenesis, many researchers have focused on the mechanical and biochemical properties of scaffolds. In addition, efforts to regulate an angiogenic and adipogenic microenvironment in cell-free settings involve integrating growth factors or extracellular matrix (ECM) proteins onto bioactive scaffolds. Despite the theoretical feasibility and encouraging results in animal models, few of the reported cell-free biomaterials have been tested in humans, and failures of decellularized adipose tissues in adipogenesis have also been reported. In these cases, the most likely reason was the lack of supporting vasculature. This review summarizes the current status of biomaterials without cell seeds. Related mechanisms and influencing factors of in situ adipogenesis in cell-free biomaterials, dilemma in the development of biomaterials, and future perspectives are also addressed.

Highlights

  • For cosmetic and reconstructive applications in the settings of adipose tissue damage due to aging and congenital or pathological conditions, such as traumatic defects, oncological resections, and degenerative diseases (Khan et al, 2012; Philips et al, 2014), the current strategies for delicate soft tissue replacement include autologous fat grafts, tissue fillers with synthetic materials, and adipose tissue engineering (ATE) (Gomillion and Burg, 2006; Choi et al, 2010)

  • This review summarizes the current status of biomaterials without cell seeds

  • Adipocytes are not the only type of cells in fat, and other types include inflammatory cells, pericytes, and fibroblasts (Eto et al, 2009; Yoshimura et al, 2011). Even though they constitute less than 10% of the fat volume summed up, they are indispensable in the whole picture of adipose tissue remodeling, and they should not be neglected in the development of bioscaffolds

Read more

Summary

Frontiers in Cell and Developmental Biology

For cosmetic and reconstructive purposes in the setting of small-volume adipose tissue damage due to aging, traumatic defects, oncological resections, and degenerative diseases, the current strategies for soft tissue replacement involve autologous fat grafts and tissue fillers with synthetic, bioactive, or tissue-engineered materials. They all have drawbacks such as volume shrinkage and foreign-body responses. Despite the theoretical feasibility and encouraging results in animal models, few of the reported cell-free biomaterials have been tested in humans, and failures of decellularized adipose tissues in adipogenesis have been reported.

INTRODUCTION
CURRENT STRATEGIES AND CLINICAL APPLICATIONS OF SOFT TISSUE RECONSTRUCTION
Autologous Fillings
Acellular dermal matrix
Bioactive Materials
Tissue Engineering
ROLES AND LIMITATIONS OF CELL SEEDS IN ATE
CURRENT APPLICATIONS OF BIOMATERIALS WITHOUT CELL SEEDS
Extracellular Matrices
FAILURES IN IN SITU ADIPOGENESIS
Recruitment and Origin of Host Cells
Enrichment of Growth Factors and Cytokines
Supporting Role of Structural Proteins
Incorporation of Other Substances
Findings
CONCLUSION AND FUTURE PERSPECTIVES
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call